Venetoclax plus bortezomib and dexamethasone in heavily pretreated end‐stage myeloma patients without t(11;14): A real‐world cohort
2020; Wiley; Volume: 38; Issue: 3 Linguagem: Inglês
10.1002/hon.2736
ISSN1099-1069
AutoresTomáš Jelı́nek, Tereza Popková, Juraj Ďuraš, Jana Mihályová, Michal Kaščák, Kateřina Benková, Hana Plonková, Lucie Černá, Zdeněk Kořı́stek, Michal Šimíček, Roman Hájek,
Tópico(s)Peptidase Inhibition and Analysis
ResumoHematological OncologyVolume 38, Issue 3 p. 412-414 LETTER TO THE EDITOR Venetoclax plus bortezomib and dexamethasone in heavily pretreated end-stage myeloma patients without t(11;14): A real-world cohort Tomas Jelinek, Corresponding Author Tomas Jelinek tomas.jelinek.md@gmail.com orcid.org/0000-0002-5467-9253 Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic Faculty of Science, University of Ostrava, Ostrava, Czech Republic Correspondence Tomas Jelinek, Department of Haematooncology, University Hospital Ostrava, 17. listopadu 1790/5, Ostrava 708 52, Czech Republic. Email: tomas.jelinek.md@gmail.comSearch for more papers by this authorTereza Popkova, Tereza Popkova orcid.org/0000-0001-5885-4218 Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech RepublicSearch for more papers by this authorJuraj Duras, Juraj Duras Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic Faculty of Medicine, University of Ostrava, Ostrava, Czech RepublicSearch for more papers by this authorJana Mihalyova, Jana Mihalyova Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic Faculty of Medicine, University of Ostrava, Ostrava, Czech RepublicSearch for more papers by this authorMichal Kascak, Michal Kascak Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic Faculty of Medicine, University of Ostrava, Ostrava, Czech RepublicSearch for more papers by this authorKaterina Benkova, Katerina Benkova Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic Faculty of Medicine, University of Ostrava, Ostrava, Czech RepublicSearch for more papers by this authorHana Plonkova, Hana Plonkova Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech RepublicSearch for more papers by this authorLucie Cerna, Lucie Cerna Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic Faculty of Medicine, University of Ostrava, Ostrava, Czech RepublicSearch for more papers by this authorZdenek Koristek, Zdenek Koristek Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic Faculty of Medicine, University of Ostrava, Ostrava, Czech RepublicSearch for more papers by this authorMichal Simicek, Michal Simicek Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic Faculty of Medicine, University of Ostrava, Ostrava, Czech RepublicSearch for more papers by this authorRoman Hajek, Roman Hajek Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic Faculty of Medicine, University of Ostrava, Ostrava, Czech RepublicSearch for more papers by this author Tomas Jelinek, Corresponding Author Tomas Jelinek tomas.jelinek.md@gmail.com orcid.org/0000-0002-5467-9253 Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic Faculty of Science, University of Ostrava, Ostrava, Czech Republic Correspondence Tomas Jelinek, Department of Haematooncology, University Hospital Ostrava, 17. listopadu 1790/5, Ostrava 708 52, Czech Republic. Email: tomas.jelinek.md@gmail.comSearch for more papers by this authorTereza Popkova, Tereza Popkova orcid.org/0000-0001-5885-4218 Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech RepublicSearch for more papers by this authorJuraj Duras, Juraj Duras Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic Faculty of Medicine, University of Ostrava, Ostrava, Czech RepublicSearch for more papers by this authorJana Mihalyova, Jana Mihalyova Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic Faculty of Medicine, University of Ostrava, Ostrava, Czech RepublicSearch for more papers by this authorMichal Kascak, Michal Kascak Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic Faculty of Medicine, University of Ostrava, Ostrava, Czech RepublicSearch for more papers by this authorKaterina Benkova, Katerina Benkova Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic Faculty of Medicine, University of Ostrava, Ostrava, Czech RepublicSearch for more papers by this authorHana Plonkova, Hana Plonkova Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech RepublicSearch for more papers by this authorLucie Cerna, Lucie Cerna Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic Faculty of Medicine, University of Ostrava, Ostrava, Czech RepublicSearch for more papers by this authorZdenek Koristek, Zdenek Koristek Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic Faculty of Medicine, University of Ostrava, Ostrava, Czech RepublicSearch for more papers by this authorMichal Simicek, Michal Simicek Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic Faculty of Medicine, University of Ostrava, Ostrava, Czech RepublicSearch for more papers by this authorRoman Hajek, Roman Hajek Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic Faculty of Medicine, University of Ostrava, Ostrava, Czech RepublicSearch for more papers by this author First published: 23 April 2020 https://doi.org/10.1002/hon.2736Citations: 8 Peer Review The peer review history for this article is available at https://publons.com/publon/10.1002/hon.2736. Funding information: SGS18/PrF/2017-2018, Grant/Award Number: SGS18/PrF/2017-2018; MH CZ - DRO - FNOs/2017; SGS01/LF/2018-2019, Grant/Award Number: SGS01/LF/2018-2019; SGS02/LF/2017-2018, Grant/Award Number: SGS02/LF/2017-2018 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume38, Issue3August 2020Pages 412-414 RelatedInformation
Referência(s)